4.6 Article

Whole genome analysis reveals the genomic complexity in metastatic cutaneous squamous cell carcinoma

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Dermatology

Cumulative incidence and disease-specific survival of metastatic cutaneous squamous cell carcinoma: A nationwide cancer registry study

Selin Tokez et al.

Summary: This study investigated the cumulative incidence and disease-specific survival of patients with metastatic cutaneous squamous cell carcinoma (mcSCC) in the Dutch population and assessed patient-based risk factors. The results showed that approximately 2% of cSCCs metastasize, with higher risk for men, increasing age, and immunocompromised patients. The 5-year disease-specific survival for patients with mcSCC was high.

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2022)

Article Oncology

Complement Factor D Is a Novel Biomarker and Putative Therapeutic Target in Cutaneous Squamous Cell Carcinoma

Pegah Rahmati Nezhad et al.

Summary: The most common metastatic skin cancer, cutaneous squamous cell carcinoma (cSCC), is growing worldwide, and there are no biomarkers or therapeutic targets for high-risk cSCCs. Recent studies have identified the essential role of autocrine complement synthesis in cSCC progression. This study evaluates the role of complement Factor D (FD), the rate-limiting enzyme of the alternative complement pathway, in cSCC development. The results identify FD as a novel biomarker and potential therapeutic target for cSCC, and propose the small-molecule FD inhibitor Danicopan as a highly specific drug candidate in the therapy of advanced cSCC. Discovery of complement-associated molecular markers for cSCC progression would improve diagnosis, classification, prognostication, and targeted therapy of cSCC and its precursors in the future.

CANCERS (2022)

Review Oncology

The Multidisciplinary Management of Cutaneous Squamous Cell Carcinoma: A Comprehensive Review and Clinical Recommendations by a Panel of Experts

Ignazio Stanganelli et al.

Summary: Cutaneous squamous cell carcinoma is a common form of cancer with a high risk of relapse. Chemotherapy is not curative with severe toxicities. Anti-PD-1 inhibitors have shown potential in the treatment of this cancer.

CANCERS (2022)

Review Oncology

Update on Management Recommendations for Advanced Cutaneous Squamous Cell Carcinoma

Jesus Garcia-Foncillas et al.

Summary: Cutaneous squamous cell carcinoma (cSCC) is the second most common form of skin cancer that occurs on the head and neck. Early detection and treatment are crucial for limiting its progression and invasion. Although high-risk markers have been identified, factors predicting regional control or survival are uncertain, necessitating individualized diagnosis and management.

CANCERS (2022)

Article Oncology

Complement Factor H in cSCC: Evidence of a Link Between Sun Exposure and Immunosuppression in Skin Cancer Progression

Ellise M. Johnson et al.

Summary: Cutaneous squamous cell carcinoma (cSCC) is a common skin cancer that may be influenced by immune modulation. Sun exposure has been found to increase the levels of complement factor H (CFH), and CFH levels are higher in cSCC samples compared to normal tissue. Additionally, cSCC is associated with a higher prevalence of regulatory T cells, indicating a potential inhibitory immune response.

FRONTIERS IN ONCOLOGY (2022)

Review Cell Biology

It's Getting Complicated-A Fresh Look at p53-MDM2-ARF Triangle in Tumorigenesis and Cancer Therapy

Che-Pei Kung et al.

Summary: The relationship between P53, MDM2, and ARF plays a crucial role in tumor suppression mechanisms, but our understanding of this relationship needs to be updated in order to develop more effective cancer treatments.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2022)

Article Dermatology

Defining the incidence of cutaneous squamous cell carcinoma in coastal NSW Australia

Anna Wilson et al.

Summary: This study describes the incidence of primary cutaneous squamous cell carcinoma in coastal NSW Australia and finds that the incidence rate is higher than previously reported, suggesting a need for a reassessment of national management of the disease.

AUSTRALASIAN JOURNAL OF DERMATOLOGY (2022)

Article Oncology

Association of TP53 and CDKN2A Mutation Profile with Tumor Mutation Burden in Head and Neck Cancer

Alexander Y. Deneka et al.

Summary: This study analyzed genomic data from 1,669 HPV-negative HNSCC tumors and found that TP53 and CDKN2A mutations are associated with specific anatomic subsites and high TMB levels in HNSCC.

CLINICAL CANCER RESEARCH (2022)

Article Oncology

Cancer Progression Gene Expression Profiling Identifies the Urokinase Plasminogen Activator Receptor as a Biomarker of Metastasis in Cutaneous Squamous Cell Carcinoma

Elahe Minaei et al.

Summary: This study conducted gene expression and pathway analysis on primary and metastatic tumors of cutaneous squamous cell carcinoma (cSCC) in the head and neck region, as well as cognate lymph node metastases and matched sun-exposed skin. The analysis revealed the involvement of various genes and pathways in promoting matrix remodeling, cell survival and migration, and epithelial to mesenchymal transition in metastatic tumors. The overexpression of urokinase plasminogen activator receptor (uPAR) was validated and suggested as an important driver of metastasis in cSCC, making it a potential therapeutic target.

FRONTIERS IN ONCOLOGY (2022)

Correction Cell Biology

Gene regulation by long non-coding RNAs and its biological functions (vol 22, pg 96, 2021)

Luisa Statello et al.

Summary: A correction to this paper has been published at the specified link.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2021)

Review Dermatology

Immunotherapy and Systemic Treatment of Cutaneous Squamous Cell Carcinoma

Nader Aboul-Fettouh et al.

Summary: Cutaneous squamous cell carcinomas (cSCC) are among the most common non-melanoma skin cancers, with treatment depending on whether it is early stage/low risk or locally advanced/metastatic. Therapeutic approaches include surgery, radiation, and systemic therapies, with recent immunotherapeutics showing promising tumor responses in advanced cSCC.

DERMATOLOGY PRACTICAL & CONCEPTUAL (2021)

Article Otorhinolaryngology

The significance of regional metastasis location in head and neck cutaneous squamous cell carcinoma

Craig P. Mooney et al.

Summary: This study found that regional metastasis of head and neck cutaneous squamous cell carcinoma to the neck confers worse outcomes compared to metastasis to the parotid alone.

HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2021)

Article Oncology

Long non-coding RNA LINC01003 suppresses the development of multiple myeloma by targeting miR-33a-5p/PIM1 axis

Linlin Wu et al.

Summary: This study revealed that low expression of LINC01003 in MM, upregulation of LINC01003 and downregulation of miR-33a-5p could inhibit cell survival and adhesion of MM cells, and promote cell apoptosis. Additionally, LINC01003 could inhibit the development of MM by regulating miR-33a-5p and PIM1.

LEUKEMIA RESEARCH (2021)

Article Genetics & Heredity

The landscape of driver mutations in cutaneous squamous cell carcinoma

Darwin Chang et al.

Summary: Cutaneous squamous cell carcinoma originates from keratinocytes in the skin and is characterized by high mutation burden primarily caused by UV-induced DNA damage. Through meta-analysis of sequencing data, multiple driver genes were identified, offering potential therapeutic targets and insights into the biology of this type of skin cancer.

NPJ GENOMIC MEDICINE (2021)

Article Biotechnology & Applied Microbiology

GRIDSS2: comprehensive characterisation of somatic structural variation using single breakend variants and structural variant phasing

Daniel L. Cameron et al.

Summary: GRIDSS2 is the first structural variant caller that explicitly reports single breakends breakpoints where only one side can be unambiguously determined. It can explain somatic centromere copy number changes using single breakends to non-centromere sequence.GRIDSS2 achieves a low false negative rate and false discovery rate in metastatic cancers, also identifying a novel duplication signature.

GENOME BIOLOGY (2021)

Article Biochemistry & Molecular Biology

Immunosuppression by Mutated Calreticulin Released from Malignant Cells

Peng Liu et al.

MOLECULAR CELL (2020)

Article Multidisciplinary Sciences

The repertoire of mutational signatures in human cancer

Ludmil B. Alexandrov et al.

NATURE (2020)

Article Multidisciplinary Sciences

The genomic landscape of metastatic breast cancer: Insights from 11,000 tumors

Jacob Rinaldi et al.

PLOS ONE (2020)

Article Medicine, General & Internal

TP53 mutational landscape of metastatic head and neck cancer reveals patterns of mutation selection

Apostolos Klinakis et al.

EBIOMEDICINE (2020)

Article Medical Laboratory Technology

COLEC12 regulates apoptosis of osteosarcoma through Toll-like receptor 4-activated inflammation

Guang-Zhang Li et al.

JOURNAL OF CLINICAL LABORATORY ANALYSIS (2020)

Article Oncology

Integrated Informatics Analysis of Cancer-Related Variants

Kymberleigh A. Pagel et al.

JCO CLINICAL CANCER INFORMATICS (2020)

Article Biochemistry & Molecular Biology

Cross-species genomics identifies DLG2 as a tumor suppressor in osteosarcoma

Yang W. Shao et al.

ONCOGENE (2019)

Article Oncology

Cutaneous Squamous Cell Carcinoma

Abigail Waldman et al.

HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2019)

Article Dermatology

Mutational Patterns in Metastatic Cutaneous Squamous Cell Carcinoma

Simon A. Mueller et al.

JOURNAL OF INVESTIGATIVE DERMATOLOGY (2019)

Review Biochemistry & Molecular Biology

Complement System in Cutaneous Squamous Cell Carcinoma

Pilvi Riihila et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)

Review Oncology

Role of the complement system in the tumor microenvironment

Ronghua Zhang et al.

CANCER CELL INTERNATIONAL (2019)

Article Multidisciplinary Sciences

Pan-cancer whole-genome analyses of metastatic solid tumours

Peter Priestley et al.

NATURE (2019)

Article Biochemistry & Molecular Biology

COSMIC: the Catalogue Of Somatic Mutations In Cancer

John G. Tate et al.

NUCLEIC ACIDS RESEARCH (2019)

Article Dermatology

Nationwide Incidence of Metastatic Cutaneous Squamous Cell Carcinoma in England

Zoe C. Venables et al.

JAMA DERMATOLOGY (2019)

Review Oncology

The Untranslated Regions of mRNAs in Cancer

Samantha L. Schuster et al.

TRENDS IN CANCER (2019)

Article Medicine, General & Internal

PD-1 Blockade with Cemiplimab in Advanced Cutaneous Squamous-Cell Carcinoma

M. R. Migden et al.

NEW ENGLAND JOURNAL OF MEDICINE (2018)

Article Genetics & Heredity

MutationalPatterns: comprehensive genome-wide analysis of mutational processes

Francis Blokzijl et al.

GENOME MEDICINE (2018)

Article Multidisciplinary Sciences

The genomic landscape of cutaneous SCC reveals drivers and a novel azathioprine associated mutational signature

Gareth J. Inman et al.

NATURE COMMUNICATIONS (2018)

Review Otorhinolaryngology

Reviewing the genetic alterations in high-risk cutaneous squamous cell carcinoma: A search for prognostic markers and therapeutic targets

Bruce G. Ashford et al.

HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2017)

Meeting Abstract Oncology

Complement component C9 as a new biomarker for esophageal adenocarcinoma.

Virendra Joshi et al.

JOURNAL OF CLINICAL ONCOLOGY (2017)

Article Multidisciplinary Sciences

Whole-genome landscapes of major melanoma subtypes

Nicholas K. Hayward et al.

NATURE (2017)

Article Biochemistry & Molecular Biology

Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients

Ahmet Zehir et al.

NATURE MEDICINE (2017)

Article Biochemistry & Molecular Biology

Universal Patterns of Selection in Cancer and Somatic Tissues

Inigo Martincorena et al.

Article Medicine, Research & Experimental

Identification of OAT1/OAT3 as Contributors to Cisplatin Toxicity

S. Hu et al.

CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2017)

Review Biochemistry & Molecular Biology

RISC assembly: Coordination between small RNAs and Argonaute proteins

Hotaka Kobayashi et al.

BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2016)

Article Multidisciplinary Sciences

Nucleotide excision repair is impaired by binding of transcription factors to DNA

Radhakrishnan Sabarinathan et al.

NATURE (2016)

Article Biochemistry & Molecular Biology

Enrichr: a comprehensive gene set enrichment analysis web server 2016 update

Maxim V. Kuleshov et al.

NUCLEIC ACIDS RESEARCH (2016)

Article Medicine, General & Internal

Implications of Genetic and Epigenetic Alterations of CDKN2A (p16INK4a) in Cancer

Ran Zhao et al.

EBIOMEDICINE (2016)

Article Biotechnology & Applied Microbiology

OncodriveFML: a general framework to identify coding and non-coding regions with cancer driver mutations

Loris Mularoni et al.

GENOME BIOLOGY (2016)

Article Biochemical Research Methods

DSigDB: drug signatures database for gene set analysis

Minjae Yoo et al.

BIOINFORMATICS (2015)

Article Oncology

Genomic Analysis of Metastatic Cutaneous Squamous Cell Carcinoma

Yvonne Y. Li et al.

CLINICAL CANCER RESEARCH (2015)

Article Oncology

Mutational Landscape of Aggressive Cutaneous Squamous Cell Carcinoma

Curtis R. Pickering et al.

CLINICAL CANCER RESEARCH (2014)

Article Oncology

Deletion of Ptprd and Cdkn2a cooperate to accelerate tumorigenesis

Berenice Ortiz et al.

ONCOTARGET (2014)

Article Multidisciplinary Sciences

Mutational heterogeneity in cancer and the search for new cancer-associated genes

Michael S. Lawrence et al.

NATURE (2013)

Article Biochemistry & Molecular Biology

Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal

Jianjiong Gao et al.

SCIENCE SIGNALING (2013)

Review Biochemistry & Molecular Biology

Regulation of eukaryotic gene expression by the untranslated gene regions and other non-coding elements

Lucy W. Barrett et al.

CELLULAR AND MOLECULAR LIFE SCIENCES (2012)

Article Cell Biology

Down-regulated miR-331-5p and miR-27a are associated with chemotherapy resistance and relapse in leukaemia

Dan-Dan Feng et al.

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2011)

Article Biochemical Research Methods

Upregulation of plasma C9 protein in gastric cancer patients

Poh-Kuan Chong et al.

PROTEOMICS (2010)

Article Multidisciplinary Sciences

The tyrosine phosphatase PTPRD is a tumor suppressor that is frequently inactivated and mutated in glioblastoma and other human cancers

Selvaraju Veeriah et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)

Review Pharmacology & Pharmacy

Organic anion transporter (Slc22a) family members as mediators of toxicity

DH Sweet

TOXICOLOGY AND APPLIED PHARMACOLOGY (2005)

Review Oncology

Cytostatic and apoptotic actions of TGF-beta in homeostasis and cancer

PM Siegel et al.

NATURE REVIEWS CANCER (2003)

Article Biochemistry & Molecular Biology

Functions of lumican and fibromodulin: Lessons from knockout mice

S Chakravarti

GLYCOCONJUGATE JOURNAL (2002)